	US 12,138,290 B2
	Micro-fog anti pathogenic composition and method of preparation
David Paul Kutchinski, Larkspur, CO (US)
Filed by David Paul Kutchinski, Larkspur, CO (US)
Filed on Dec. 30, 2020, as Appl. No. 17/138,221.
Prior Publication US 2022/0202891 A1, Jun. 30, 2022
Int. Cl. A61K 36/53 (2006.01); A61K 35/644 (2015.01); A61K 36/00 (2006.01); A61K 36/185 (2006.01); A61K 36/24 (2006.01); A61K 36/315 (2006.01); A61K 36/484 (2006.01); A61K 36/537 (2006.01); A61K 36/539 (2006.01); A61K 36/71 (2006.01); A61K 36/9068 (2006.01); A61K 47/02 (2006.01)

CPC A61K 36/53 (2013.01) [A61K 35/644 (2013.01); A61K 36/185 (2013.01); A61K 36/24 (2013.01); A61K 36/315 (2013.01); A61K 36/484 (2013.01); A61K 36/537 (2013.01); A61K 36/539 (2013.01); A61K 36/71 (2013.01); A61K 36/9068 (2013.01); A61K 47/02 (2013.01)]

3 Claims

1. A method of producing an anti-pathogenic composition, comprising the method steps of:

a. admixing components to form a formulation as a solution comprising by weight percent of the solution of

0.06% Lavandula augustifola, 0.08% Scutellaria baicanlensis, 0.11% Nigella sativa, 0.09% Sida Acuta, 0.08% Cryptolepsis, 0.08% Isatis tinctoria, 0.11% Glycyrrhiza glabra, 0.07% Salvia officinalis, 2.89% medicinal honey, and 0.12% Zingiber officinale,

and a colloidal silver base;

b. increasing the admixed component mixture with ≥30% hydrogen peroxide solution at a rate of 45 RPM; and

c. stirring the admixture of step (a) at room temperature by using a magnetic or electric overhead stirrer.